BioSpace News Archive

Alphatec Holdings, Inc. announced that at the 2022 NASS Annual Meeting, the Company will introduce expandable interbody and access technology designed to enhance the medialized minimally-invasive posterior approach.

ANGLE plc, a world-leading liquid biopsy company, is pleased to announce it has signed a distribution agreement with Promedeus s.r.o to enable and support the roll out of the FDA cleared and CE marked Parsortix® PC1 system across the Czech Republic for its intended use in metastatic breast cancer.

Sangamo Therapeutics, Inc., a genomic medicine company, announced updated preliminary results from the Phase 1/2 STAAR clinical study evaluating isaralgagene civaparvovec, or ST-920, a wholly owned gene therapy product candidate for the treatment of Fabry disease.

Phonak, a leading global provider of life-changing hearing solutions, announces that Oliver Frank will be taking up the position as Vice President Phonak Marketing effective December 1, 2022.

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses and diseases, announced the expansion of its leadership team with the appointment of Dr.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) today announced the inaugural International Meeting on Pathway-Related Obesity: Vision of Excellence (IMPROVE) 2022 in Berlin, Germany from October 12-14.

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer, and Dr. Michelle Berrey, President of R&D and Chief Medical Officer of Intercept will participate in a fireside chat at H.C. Wainwright’s 6th Annual NASH Investor Conference.